Johnson & Johnson has published the 2020 Health for Humanity Report (Report), which serves as the Company’s annual disclosure on environmental, social and governance (ESG) performance and illustrates progress toward fulfilling its corporate purpose to change the trajectory of health for humanity. The Report documents the Company’s performance and provides information on how the Company generates long-term social, environmental and economic value for all stakeholders; provides an accounting of the final year of progress against the Johnson & Johnson Health for Humanity 2020 Goals and U.N. Sustainable Development Goals Commitment; and…
Read MoreTag: Johnson & Johnson
Enel Green Power Espana announces a 10-year agreement for a fully renewable energy supply with Johnson & Johnson
Enel Green Power España, has signed a 10-year, fully renewable Pan-European Virtual Power Purchase Agreement (VPPA) with the international healthcare company Johnson & Johnson for 270 GWh/year of renewable power originated from a total generation capacity of 104 MW. This VPPA will start in January 2023 and, along with other agreements previously signed by the international healthcare company, will bring Johnson & Johnson to the equivalent of 100% renewable electricity in Europe by 2023. This is a huge step towards its climate goal of 100% renewable electricity globally by 2025.…
Read MoreJohnson & Johnson Vision Reinforces Sustainability Commitment
Johnson & Johnson Vision, a global leader in eye health and manufacturer of ACUVUE® brand contact lenses, today announced that it has signed a 10-year deal with JEA which will see 100% of the electricity at its global headquarters in Jacksonville, Florida come from solar power. The agreement reinforces the company’s commitment to sustainability with the business to be on track to source 100% of its electricity from renewable sources by 2025, as well as achieve carbon neutrality across all its operations by 2030, as part of Johnson & Johnson’s…
Read MoreJohnson & Johnson Launches Heartline™, the First-of-Its-Kind, Virtual Study Designed to Explore if a New App can Help Reduce Stroke Risk
Johnson & Johnson has announced that the Janssen Pharmaceutical Companies of Johnson & Johnson, in collaboration with Apple, opened enrollment for the Heartline Study. The study is designed to explore if the Heartline Study app on iPhone and heart health features on Apple Watch can improve health outcomes, including reducing the risk of stroke, with earlier detection of atrial fibrillation (AFib). AFib, a common form of irregular heart rhythm, is a leading cause of stroke in the U.S. To enroll in the Heartline Study, individuals must be age 65 or…
Read MoreJohnson & Johnson Releases Inaugural You Belong: Diversity & Inclusion Impact Review
Johnson & Johnson, the world’s largest and most broadly-based healthcare company, has published You Belong: Diversity & Inclusion Impact Review (Impact Review), which demonstrates how a strategic Diversity & Inclusion (D&I) philosophy has been a key driver of innovation and impactful business outcomes since its founding more than 130 years ago. Through collaborative achievements and personal stories, the Impact Review explores how the collective wisdom and commitment to inclusion of the 135,000 Johnson & Johnson employees power the company’s spirit, and serve patients, customers, and consumers every day. “We believe that…
Read More